Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma
Yanqiu Zhang, Yaling Li, Hongwei Yan Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of ChinaCorrespondence: Hongwei Yan, Department of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, People’s Republic of C...
Main Authors: | Zhang Y, Li Y, Yan H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-02-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Subjects: | |
Online Access: | https://www.dovepress.com/low-expression-of-clec2b-indicates-poor-prognosis-in-melanoma-peer-reviewed-fulltext-article-CCID |
Similar Items
-
CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
by: Jiaxing Sun, et al.
Published: (2020-04-01) -
CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma
by: Liang X, et al.
Published: (2022-06-01) -
CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
by: Xing-Wei Xie, et al.
Published: (2021-01-01) -
The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis
by: Minjia Sheng, et al.
Published: (2024-04-01) -
Identification of an immune-related signature for the prognosis of uveal melanoma
by: Ying-Zi Li, et al.
Published: (2020-03-01)